Meeting NewsVideo

VIDEO: Presbyopic IOL offers novel design

NEW YORK — In his presentation at OSN New York 2019, Uday Devgan, MD, demonstrates the insertion of the Juvene accommodating IOL (LensGen) and discusses its success rate. An FDA trial for the lens is expected to begin in early 2020.

NEW YORK — In his presentation at OSN New York 2019, Uday Devgan, MD, demonstrates the insertion of the Juvene accommodating IOL (LensGen) and discusses its success rate. An FDA trial for the lens is expected to begin in early 2020.

    See more from OSN New York